Substance abuse treatment duration for medicaid versus commercial clients in a health maintenance organization

Medical Care

Volumn 44, Issue 6, 2006, Pages 601-606

  McFarland, Bentson H ^a,b,c   Lynch, Frances L ^a,c   Freeborn, Donald K ^a,c   Green, Carla A ^a,b,c   Polen, Michael R ^a   Deck, Dennis D ^d   Dickinson, Daniel M ^e  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d RMC RESEARCH CORPORATION   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

Enrollment duration; Health maintenance organization; Medicaid; Substance abuse treatment

Indexed keywords

ADDICTION; ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MALE; MEDICAID; PROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; TIME;

ADULT; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 33745313758     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000215814.01127.ce     Document Type: Review

References (43)

1. Weisner CM. What is the scope of the problem and its impact on health and social systems? In: Miller WR, Weisner CM, eds. Changing Substance Abuse Through Health and Social Systems. New York: Kluwer Academic/Plenum Publishers; 2002:3-14.
2. Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States, 1992-1998. Washington, DC: Executive Office of the President (publication no. NCJ-190636); 2001.
3. National Institute of Health. Special Report to the US Congress on Alcohol and Health. Bethesda, MD: US Department of Health and Human Services (publication no. 00-1583); 2000.
4. Weisner C, Mertens J, Parthasarathy S, et al. Integrating primary medical care with addiction treatment. JAMA. 2001;286:1715-1723.
5. Friedmann PD, Zhang Z, Hendrickson J, et al. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003;18:1-8.
6. Parthasarathy S, Weisner C, Hu T, et al. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. J Stud Alcohol. 2001;62:89-97.
7. Gerson LW, Boex J, Hua K, et al. Medical care use by treated and untreated substance abusing Medicaid patients. J S Subst Abuse Treat. 2001;20:115-120.
8. Wickizer TM. The Impact of Substance Abuse Treatment on Employment Outcomes Among AFDC Clients in Washington State. Rockville, MD: US Department of Health and Human Services, Center for Substance Abuse Treatment (publication no SMA 02-3708); 2001.
9. Monahan SC, Finney JW. Explaining abstinence rates following treatment for alcohol abuse: a quantitative synthesis of patient, research design, and treatment effects. Addiction. 1996;91:787-805.
10. Simpson DD, Brown BS. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcomes Study (DATOS). Psychol Addict Behav. 1997;11:294-307.
11. Simpson DD, Joe GW, Broome KM, et al. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcomes Study (DATOS). Psychol Addict Behav. 1997;11:297-293.
12. D'Aunno T. Overview. In: Galanter M, ed. Recent Developments in Alcoholism, Volume 15: Services Research in the Era of Managed Care. New York: Kluwer Academic/Plenum Publishers; 2001:3-6.
13. Etheridge RM, Craddock SG, Hubbard RL, et al. The relationship of counseling and self-help participation to patient outcomes in DATOS. Drug Alcohol Depend. 1999;57:99-112.
14. Grella CE, Hser YI, Joshi V, et al. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug Alcohol Depend. 1999;57:151-166.
15. Hser YI, Grella C, Chou CP, et al. Relationships between drug treatment careers and outcomes. Findings from the national Drug Abuse Treatment Outcome Study. Evaluation Review. 1998;22:496-519.
16. Hser YI, Grella CE, Hsieh SC, et al. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999;57: 137-150.
17. Hser YI, Grella CE, Hubbard RL, et al. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry. 2001;58:689-695.
18. Moos RH, Finney JW, Federman EB, et al. Specialty mental health care improves patients' outcomes: findings from a nationwide program to monitor the quality of care for patients with substance use disorders. J Stud Alcohol. 2000;61:704-713.
19. Moos RH, Pettit B, Gruber V. Longer episodes of community residential care reduce substance abuse patients' readmission rates. J Stud Alcohol. 1995;56:433-443.
20. National Institutes of Health. Principles of Drug Addiction Treatment: A Research Based Guide. NIH publication no. 00-4180; October 1999.
21. Garnick DW, Lee MT, Chalk M, et al. Establishing the feasibility of performance measures for alcohol and other drugs. J Subst Abuse Treat, 2002;23:375-385.
22. Galanter M, Keller DS. Dermatis H, et al. The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine. J Addict Dis. 2000; 19:13-34.
23. Olmstead T, White WD, Sindelar J. The impact of managed care on substance abuse treatment services. Health Serv Res. 2004;39:319-343.
24. Weisner C, Schmidt L. Alcohol and drug problems among diverse health and social service populations. Am J Public. Health. 1993;83:824-829.
25. Jayakody R, Danziger S, Pollack H. Welfare reform, substance use, and mental health. J Health Polit Policy Law. 2000;25:623-651.
26. Hurley RE, Somers SA. Medicaid and managed care: a lasting relationship? Managed Care. 2003:77-88.
27. Normand ST, Belanger AJ, Frank RG. Evaluating selection out of health plans for Medicaid beneficiaries with substance abuse. J Behav Health Serv Res. 2003;30:1.
28. Green CA, Polen MR, Dickinson DM, et al. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abuse Treat. 2002;23:285-295.
29. Ettner SL, Denmead G, Dilonardo J, et al. The impact of managed care on the substance abuse treatment patterns and outcomes of Medicaid beneficiaries: Maryland's HealthChoice program. J Behav Health Serv Res. 2003;30:41-62.
30. Walter LJ, Parthasarathy S, Allen S, et al. Medicaid patients in a private health maintenance organization: patterns of chemical dependency treatment. J Behav Health Serv Res. 2002;29:1-14.
31. Cutler DL, McFarland BH, Winthrop K. Mental health in the Oregon Health Plan: fragmentation or integration? Adm Policy Ment Health. 1998;25:361-386.
32. McFarland BH. Overview of Medicaid managed behavioral health care. In: Goetz RR, McFarland BH, Ross KV, eds. What the Oregon Health Plan Can Teach Us About Managed Mental Health Care. New Directions for Mental Health Services, no 85. San Francisco: Jossey-Bass; 2000.
33. Laws K, Gabriel R, McFarland B. Impact of Medicaid managed care on substance abuse treatment. Health Aff (Millwood). 2002;21:284-289.
34. Deck DD, McFarland BH, Titus JM, et al. Access to substance abuse treatment services under the Oregon Health Plan. JAMA. 2000;284: 2093-2099.
35. Deck DD, McFarland BH. Datapoints: Medicaid managed care and substance abuse treatment. Psychiatr Serv. 2002;53:802.
36. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
37. Rosenbaum PR, Rubin DB. Constructing a control using multivariate matched sampling methods that incorporate the propensity score. American Statistician. 1985;39:33-38.
38. Berk RA, Newton PJ, Berk SF. What a difference a day makes: an empirical study of the impact of shelters for battered women. Journal of Marriage and Family. 1986;48:481-490.
39. Berk RA, Newton PJ. Does arrest really deter wife battery? An effort to replicate the findings of the Minneapolis Spouse Abuse experiment. Am Sociological Rev. 1985;50:253-262.
40. Stone RA, Obrosky DS, Singer DE, et al. Propensity score adjustment for pretreatment differences between hospitalized and ambulatory patients with community-acquired pneumonia. Pneumonia Patient Outcomes Research Team (PORT) Investigators. Med Care. 1995;33(suppl):AS56-AS66.
41. Mojtabai R, Zivin JG. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis. Health Serv Res. 2003;38:233-259.
42. McCorry F, Garnick D, Bartlett J, et al. Developing performance measures for alcohol and other drug services in managed care plans. Jt Comm J Qual Improv. 2000;26:633-643.
43. Singer JD, Willett JB. Applied Longitudinal Data Analysis. Oxford: Oxford University Press; 2003.